Advanced Biomed ADVB
NASDAQ ADVB
$2.53 -0.78 (-23.56%)
At close: Nov 13, 2026 · 4:00 PM EST

Advanced Biomed (ADVB) Gains from Sales and Divestitures (2025 - 2026)

Updated

Advanced Biomed (ADVB) recorded Gains from Sales and Divestitures of $6.67 million in fiscal Q4 2026 (quarter ended Jun 30, 2026).

Analysis

Advanced Biomed (ADVB) Gains from Sales and Divestitures (2025 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Advanced Biomed reported Gains from Sales and Divestitures of $14.02 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn
10 Advanced Biomed 4.18 Mn -1.64 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.67 Mn
Dec 31, 2025 7.35 Mn
Sep 30, 2025 61.00
API Access

Advanced Biomed Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ADVB&period=max&api_key=YOUR_API_KEY